Stocks Seeing Increasingly Wild Swings After Earnings
Earnings beats aren’t enough to steady markets as stocks see bigger, more persistent swings. The article explains wha...
Which Dividend Etf Has Lowest Fees
We examine Which Dividend Etf Has Lowest Fees and outline criteria for evaluating expense transparency, trading costs, and overall value.
27,609 articlesFederal Civil Rights Agency Scraps 60-Year Diversity Rule
The federal civil rights agency voted 2-1 to terminate a 60-year-old workforce diversity reporting rule, a move that ...
Palantir’s Stock Dropped Third as Burry Unveils New Attack Plan
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
OpenAI Codex Usage Surges Past 1 Million Weekly Users
OpenAI reports Codex downloads exceed 1 million with over 1 million weekly active users, signaling a shift toward Cod...
Strategy’s Stock Soars February, Doubling Bitcoin Gains
Strategy’s stock soared february, jumping 35% from its February low and outpacing bitcoin’s gains as investors price ...
Inside Mark Kvamme’s Second Bet: Ohio Growth Push
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
SanDisk Soars, Western Digital Rally as Memory Stocks Rebound
Memory names bounced Thursday, with SanDisk up 9%, Western Digital rising 5%, and Micron gaining 3% as AI-driven stor...
Netflix Nearing 52-Week Low: Buy, Sell or Hold Now?
Netflix is trading near its 52-week low as ad-supported growth and cash flow gains reshape investor bets. Analysts di...
From Maker Giant: Dell Rises on AI Bets and Backlogs
Dell Technologies pivots from PC maker to AI infrastructure leader, as it visits higher backlog levels and raises rev...
Beaten-Down Stocks That Could Roar Back in June 2026
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...
10-Year SpaceX Investor Says Valuation Is Too Cheap
A veteran SpaceX backer contends the $2 trillion IPO valuation understates the long-term growth in space infrastructu...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status